events. It may also address the, at times, much more interesting question of resilience. Nevertheless, the fact that many of the female specific mood and anxiety disorders have an adult or late onset seem to indicate that genetic factors play only a small or partial role in their pathogenesis.
To complicate matters even further, women, from the age of menarche and on, are exposed to the effects of fluctuations in gonadal steroids throughout their menstrual cycles, during pregnancy, postpartum, perimenopause, menopause and beyond. These, at times, abrupt changes along the hypothalamic-pituitary-gonadal axis interact with the stressinduced activation of the hypothalamic-pituitary-adrenal axis in a manner that is yet not fully understood.
Again, hormonal fluctuations alone do not cause premenstrual, perinatal or perimenopausal mood/anxiety disorders. The effects of reproductive steroids on the brain are highly context dependent, but these female specific mood disorders provide an opportunity like no other to study endocrine related mood and anxiety disorders. Moreover, it is now evident that the brains of women and men are anatomically, chemically and functionally different and that some of these variations occur in brain regions involved in emotion, cognition, memor y and behaviour. Fur ther discoveries in this field could point the way to sex-specific therapies for both women and men with mental disorders.
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It is hoped that within the next decade we will be able to identify specific genetic markers which might help us better understand how the balance between female reproductive neuroendocrine events, neurotransmitter function, sensitivities to psychosocial, environmental and physiological factors relate to women's mental health.
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Whether psychiatric genetics will find these pathways to discovery remains to be seen.
